Marta Rigoni, Valeria Cento, Carlo Federico Perno, Martina Barchitta, Antonella Agodi, Sergio Bonini, Fabiana Furci, Silvana D'Alessio, Simona Barbaglia, Sandra Frateiacci, Annarosa Racca, Giuseppe Fornasa, Francesco Broccolo, Guido Rasi, Giuseppe Recchia, Lucio Da Ros, Giandomenico Nollo
{"title":"用于预防和控制呼吸道过敏和感染的鼻内过滤器。多方利益相关者评估。","authors":"Marta Rigoni, Valeria Cento, Carlo Federico Perno, Martina Barchitta, Antonella Agodi, Sergio Bonini, Fabiana Furci, Silvana D'Alessio, Simona Barbaglia, Sandra Frateiacci, Annarosa Racca, Giuseppe Fornasa, Francesco Broccolo, Guido Rasi, Giuseppe Recchia, Lucio Da Ros, Giandomenico Nollo","doi":"10.1701/4518.45174","DOIUrl":null,"url":null,"abstract":"<p><p>Healthcare innovations aim to develop and provide technologies, services, and health policies to improve population health and well-being at a global level. Among innovative medical devices (MD), endonasal filters (EF) are designed to improve breathing and capture fine dust and allergens in the surrounding environment acting as a mechanical barrier to the passage of allergens, pathogenic microorganisms and dust. This paper aimed to: i) review the features of EF commercially available, regulatory classification, and their potential role in public health as useful innovative devices; ii) review their role in prevention and control of respiratory infections; iii) review their role in prevention and control of allergic respiratory diseases. A review of MD on the market was carried out through official Ministry of Health, commercial and pharmaceutical channels. Moreover, three separate literature reviews were done by the involved multidisciplinary team. The analysis of the European market, with particular attention to Italy, on available MD identified seven brands of EF. A search conducted at 16th April 2023 in Italian MD Database of the Ministry of Health revealed that three products were registered as MD and they were available on the Italian market. Literature review found 3 studies on nasal filter technical description, 4 studies on patients on infectious diseases and other applications, and 13 studies on patients on respiratory allergy. Studies on infectious diseases were one review, and one correspondence reporting a research proposal. Studies on respiratory allergy included 3 randomized controlled studies, 5 observational open-label non-randomized studies, 2 case series, 1 case report, 1 review, and 1 systematic review. Despite reasonable theoretical fundamentals to claim that EF might contribute to the reduction of infection viral load, current evidence supporting the use of such filters is still scarce, suggesting the need to further research and comprehensive assessments for developing ad hoc documents, guidelines and recommendations.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 6","pages":"357-370"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endonasal filters for the prevention and control of respiratory allergy and infections. A multi-stakeholder assessment.\",\"authors\":\"Marta Rigoni, Valeria Cento, Carlo Federico Perno, Martina Barchitta, Antonella Agodi, Sergio Bonini, Fabiana Furci, Silvana D'Alessio, Simona Barbaglia, Sandra Frateiacci, Annarosa Racca, Giuseppe Fornasa, Francesco Broccolo, Guido Rasi, Giuseppe Recchia, Lucio Da Ros, Giandomenico Nollo\",\"doi\":\"10.1701/4518.45174\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Healthcare innovations aim to develop and provide technologies, services, and health policies to improve population health and well-being at a global level. Among innovative medical devices (MD), endonasal filters (EF) are designed to improve breathing and capture fine dust and allergens in the surrounding environment acting as a mechanical barrier to the passage of allergens, pathogenic microorganisms and dust. This paper aimed to: i) review the features of EF commercially available, regulatory classification, and their potential role in public health as useful innovative devices; ii) review their role in prevention and control of respiratory infections; iii) review their role in prevention and control of allergic respiratory diseases. A review of MD on the market was carried out through official Ministry of Health, commercial and pharmaceutical channels. Moreover, three separate literature reviews were done by the involved multidisciplinary team. The analysis of the European market, with particular attention to Italy, on available MD identified seven brands of EF. A search conducted at 16th April 2023 in Italian MD Database of the Ministry of Health revealed that three products were registered as MD and they were available on the Italian market. Literature review found 3 studies on nasal filter technical description, 4 studies on patients on infectious diseases and other applications, and 13 studies on patients on respiratory allergy. Studies on infectious diseases were one review, and one correspondence reporting a research proposal. Studies on respiratory allergy included 3 randomized controlled studies, 5 observational open-label non-randomized studies, 2 case series, 1 case report, 1 review, and 1 systematic review. Despite reasonable theoretical fundamentals to claim that EF might contribute to the reduction of infection viral load, current evidence supporting the use of such filters is still scarce, suggesting the need to further research and comprehensive assessments for developing ad hoc documents, guidelines and recommendations.</p>\",\"PeriodicalId\":20887,\"journal\":{\"name\":\"Recenti progressi in medicina\",\"volume\":\"116 6\",\"pages\":\"357-370\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Recenti progressi in medicina\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1701/4518.45174\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recenti progressi in medicina","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1701/4518.45174","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Endonasal filters for the prevention and control of respiratory allergy and infections. A multi-stakeholder assessment.
Healthcare innovations aim to develop and provide technologies, services, and health policies to improve population health and well-being at a global level. Among innovative medical devices (MD), endonasal filters (EF) are designed to improve breathing and capture fine dust and allergens in the surrounding environment acting as a mechanical barrier to the passage of allergens, pathogenic microorganisms and dust. This paper aimed to: i) review the features of EF commercially available, regulatory classification, and their potential role in public health as useful innovative devices; ii) review their role in prevention and control of respiratory infections; iii) review their role in prevention and control of allergic respiratory diseases. A review of MD on the market was carried out through official Ministry of Health, commercial and pharmaceutical channels. Moreover, three separate literature reviews were done by the involved multidisciplinary team. The analysis of the European market, with particular attention to Italy, on available MD identified seven brands of EF. A search conducted at 16th April 2023 in Italian MD Database of the Ministry of Health revealed that three products were registered as MD and they were available on the Italian market. Literature review found 3 studies on nasal filter technical description, 4 studies on patients on infectious diseases and other applications, and 13 studies on patients on respiratory allergy. Studies on infectious diseases were one review, and one correspondence reporting a research proposal. Studies on respiratory allergy included 3 randomized controlled studies, 5 observational open-label non-randomized studies, 2 case series, 1 case report, 1 review, and 1 systematic review. Despite reasonable theoretical fundamentals to claim that EF might contribute to the reduction of infection viral load, current evidence supporting the use of such filters is still scarce, suggesting the need to further research and comprehensive assessments for developing ad hoc documents, guidelines and recommendations.
期刊介绍:
Giunta ormai al sessantesimo anno, Recenti Progressi in Medicina continua a costituire un sicuro punto di riferimento ed uno strumento di lavoro fondamentale per l"ampliamento dell"orizzonte culturale del medico italiano. Recenti Progressi in Medicina è una rivista di medicina interna. Ciò significa il recupero di un"ottica globale e integrata, idonea ad evitare sia i particolarismi della informazione specialistica sia la frammentazione di quella generalista.